| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |